Information Provided By:
Fly News Breaks for May 16, 2017
BSX
May 16, 2017 | 06:36 EDT
Goldman Sachs analyst Isaac Ro started Boston Scientific with a Neutral rating and $28 price target. The analyst views the company's "solid" growth as fairly valued.